These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8114899)

  • 1. Patent medicines.
    Coulson AF
    Nature; 1994 Jan; 367(6459):108. PubMed ID: 8114899
    [No Abstract]   [Full Text] [Related]  

  • 2. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 3. Generic drug manufacturers lose patent protection battle.
    McGourty C
    Nature; 1988 Oct; 335(6193):756. PubMed ID: 3185701
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug costs threaten patent protection.
    Cimons M
    Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 7. Promega changes tack in battle over patent.
    Knight J
    Nature; 2003 Nov; 426(6965):373. PubMed ID: 14647346
    [No Abstract]   [Full Text] [Related]  

  • 8. "NIH-money-for-drug-patent-life" proposal rejected.
    Fox JL
    Nat Biotechnol; 1997 Dec; 15(13):1338. PubMed ID: 9415880
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent nonsense: evidence tells of an industry out of social control.
    Mintzberg H
    CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
    [No Abstract]   [Full Text] [Related]  

  • 11. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug research and development in the pharmaceutical industry.
    Cromie BW
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):9S-14S. PubMed ID: 3567038
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent protection brings hope to insurers.
    Kenyon G
    Nat Med; 2011 Sep; 17(9):1026. PubMed ID: 21900903
    [No Abstract]   [Full Text] [Related]  

  • 14. Living organisms in patent law.
    Hill MM
    Lancet; 1970 Nov; 2(7680):986-7. PubMed ID: 4097635
    [No Abstract]   [Full Text] [Related]  

  • 15. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent indicators: a window to pharmaceutical market success.
    Guo Y; Hu Y; Zheng M; Wang Y
    Expert Opin Ther Pat; 2013 Jul; 23(7):765-71. PubMed ID: 23611022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Face-off will new drugs pay off in time to counter patent losses for Forest Laboratories?
    Vukhac K; Rivkind I
    Fortune; 2012 Jun; 165(8):80. PubMed ID: 22741415
    [No Abstract]   [Full Text] [Related]  

  • 18. How Barr managed to kill Eli Lilly's patent on Prozac.
    Pabst PL
    Tissue Eng; 2001 Dec; 7(6):843-4. PubMed ID: 11749739
    [No Abstract]   [Full Text] [Related]  

  • 19. Report urges controversial 'delinkage' to foster new antibiotics.
    Holmes D
    Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363
    [No Abstract]   [Full Text] [Related]  

  • 20. AZT patent challenge.
    Dimens Health Serv; 1991 Apr; 68(3):6-7. PubMed ID: 1894090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.